Establishment and clinical application of dried blood spots and mixed leukocytes for determination of acid alpha-glucosidase activity

OBJECTIVE: Glycogen storage disease type II (GSD II, Pompe disease) is caused by the deficiency of acid alpha-glucosidase (GAA) that leads to lysosomal glycogen accumulation. Early diagnosis and treatment of GSD II are considered to be critical for maximum efficacy of the enzyme replacement therapy....

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 48(2010), 1 vom: 29. Jan., Seite 55-9
1. Verfasser: Qiu, Wen-juan (VerfasserIn)
Weitere Verfasser: Wang, Xia, Wang, Yu, Ye, Jun, Han, Lian-shu, Zhang, Hui-wen, Gu, Xue-fan
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2010
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Evaluation Study Journal Article Research Support, Non-U.S. Gov't Glucan 1,4-alpha-Glucosidase EC 3.2.1.3
LEADER 01000caa a22002652c 4500
001 NLM197820123
003 DE-627
005 20250211125741.0
007 tu
008 231223s2010 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0659.xml 
035 |a (DE-627)NLM197820123 
035 |a (NLM)20441705 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Qiu, Wen-juan  |e verfasserin  |4 aut 
245 1 0 |a Establishment and clinical application of dried blood spots and mixed leukocytes for determination of acid alpha-glucosidase activity 
264 1 |c 2010 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 03.02.2011 
500 |a Date Revised 10.12.2019 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: Glycogen storage disease type II (GSD II, Pompe disease) is caused by the deficiency of acid alpha-glucosidase (GAA) that leads to lysosomal glycogen accumulation. Early diagnosis and treatment of GSD II are considered to be critical for maximum efficacy of the enzyme replacement therapy. The aim of this study was to introduce two reliable methods and to generate the reference range of GAA activity 
520 |a METHOD: The assay of GAA activity was performed in dried blood spots (DBS) and mixed leukocytes with acarbose to eliminate isoenzyme interference and to generate the reference range. GAA activity was assayed in 700 specimens for DBS from normal subjects and 100 specimens for mixed leukocytes from normal subjects to set up reference range. GAA activity in the samples of 4 patients who were clinically suspected of GSD II and their parents were also assayed 
520 |a RESULT: The intra-run and inter-run precision of the DBS method was less than 10%. GAA activity tested by DBS was stable for 28 days between room temperature and -80 degrees C. The reference range of newborns and children-adults in DBS samples was 8.92 - 60.03 pmol/(punch x h) and 8.00 - 37.43 pmol/(punch x h), respectively. The reference range in mixed leukocytes samples was 12.56 - 50.26 nmol/(mg protein x h). Four patients were diagnosed as GSD II with the above-mentioned two methods 
520 |a CONCLUSION: The determination of GAA activity in DBS is sensitive and time-saving, and is suitable for high throughput analysis and newborn screening for GSD II. The assay of GAA activity in mixed leukocytes is accurate, fast and specific, and is suitable for final diagnosis of GSD II 
650 4 |a Evaluation Study 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Glucan 1,4-alpha-Glucosidase  |2 NLM 
650 7 |a EC 3.2.1.3  |2 NLM 
700 1 |a Wang, Xia  |e verfasserin  |4 aut 
700 1 |a Wang, Yu  |e verfasserin  |4 aut 
700 1 |a Ye, Jun  |e verfasserin  |4 aut 
700 1 |a Han, Lian-shu  |e verfasserin  |4 aut 
700 1 |a Zhang, Hui-wen  |e verfasserin  |4 aut 
700 1 |a Gu, Xue-fan  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 48(2010), 1 vom: 29. Jan., Seite 55-9  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnas 
773 1 8 |g volume:48  |g year:2010  |g number:1  |g day:29  |g month:01  |g pages:55-9 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 48  |j 2010  |e 1  |b 29  |c 01  |h 55-9